Moringa is a nutrient-dense edible leaf, most reliably valuable for supplying vitamins, minerals, and plant protein. Possible modest lowering of blood pressure and after-meal blood sugar appears mainly in people whose levels are already high, on mixed, low-quality evidence. Contamination has caused recalls; stronger medical promises remain unproven and uncertain. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Fasting blood glucose | 75–86 mg/dL | Tracks the main metabolic effect |
| Glycated hemoglobin | < 5.4% | Average blood sugar over ~3 months |
| Blood pressure (systolic/diastolic) | < 120 / < 80 mmHg | Tracks the blood-pressure effect |
| Lipid panel (LDL, HDL, triglycerides) | LDL < 100 mg/dL; triglycerides < 90 mg/dL | Detects any lipid change |
| Liver enzymes (ALT/AST) | ALT < 25 U/L (F), < 30 U/L (M) | Safety check for high-dose or extract use |
| Ferritin | 40–150 ng/mL | Reflects iron status the leaf can support |
| Thyroid-stimulating hormone | 0.5–2.5 mIU/L | Screens for possible thyroid effect |
| Creatinine / eGFR | eGFR > 90 mL/min/1.73m² | General safety and dosing context |
Cadence: Recheck at ~4 weeks and 12 weeks, then every 6–12 months; check glucose more frequently in the first 1–2 weeks if on antidiabetic therapy